LV10196A - Olbaltumviela biologiski aktivais hormons olbaltumvielas iegusanas panemiens farmaceitisks preparats - Google Patents

Olbaltumviela biologiski aktivais hormons olbaltumvielas iegusanas panemiens farmaceitisks preparats

Info

Publication number
LV10196A
LV10196A LV931256A LV931256A LV10196A LV 10196 A LV10196 A LV 10196A LV 931256 A LV931256 A LV 931256A LV 931256 A LV931256 A LV 931256A LV 10196 A LV10196 A LV 10196A
Authority
LV
Latvia
Prior art keywords
protein
biologically active
pharmaceutical preparation
active hormone
extraction
Prior art date
Application number
LV931256A
Other languages
English (en)
Other versions
LV10196B (en
Inventor
Giuseppe Arpaia
Serenella Serani
Antonino Sirna
Stefano Villa
Original Assignee
Serono Cesare Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11264576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV10196(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serono Cesare Ist Ricerca filed Critical Serono Cesare Ist Ricerca
Publication of LV10196A publication Critical patent/LV10196A/lv
Publication of LV10196B publication Critical patent/LV10196B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
LVP-93-1256A 1987-06-26 1993-11-22 Protein molecule, biologically active hormon, method of preparation thereof, pharmaceutical composition LV10196B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8748110A IT1206302B (it) 1987-06-26 1987-06-26 Ormone follicolo-stimolante urinario
PCT/IT1988/000048 WO1988010270A1 (en) 1987-06-26 1988-06-24 Urinary follicle stimulating hormone

Publications (2)

Publication Number Publication Date
LV10196A true LV10196A (lv) 1994-10-20
LV10196B LV10196B (en) 1995-04-20

Family

ID=11264576

Family Applications (2)

Application Number Title Priority Date Filing Date
LVP-93-1241A LV10628B (en) 1987-06-26 1993-11-17 Urinary follicle stimulating hormone
LVP-93-1256A LV10196B (en) 1987-06-26 1993-11-22 Protein molecule, biologically active hormon, method of preparation thereof, pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LVP-93-1241A LV10628B (en) 1987-06-26 1993-11-17 Urinary follicle stimulating hormone

Country Status (26)

Country Link
US (3) US5128453A (lv)
EP (1) EP0322438B1 (lv)
JP (1) JP2523843B2 (lv)
KR (1) KR0156565B1 (lv)
CN (2) CN1031714C (lv)
AR (1) AR243241A1 (lv)
AT (1) ATE115148T1 (lv)
AU (1) AU615930B2 (lv)
CA (1) CA1340649C (lv)
DE (1) DE3852383T2 (lv)
DK (1) DK173349B1 (lv)
ES (1) ES2009948A6 (lv)
FI (1) FI96608C (lv)
GE (2) GEP19971042B (lv)
GR (1) GR1003186B (lv)
HK (1) HK143195A (lv)
IL (1) IL86847A (lv)
IT (1) IT1206302B (lv)
LT (2) LT4018B (lv)
LV (2) LV10628B (lv)
MX (1) MX9203471A (lv)
NO (1) NO177498C (lv)
RU (2) RU2059412C1 (lv)
UA (1) UA19101A (lv)
WO (1) WO1988010270A1 (lv)
ZA (1) ZA884492B (lv)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1270866B (it) * 1993-03-10 1997-05-13 Eniricerche Spa Vettore ricombinante e suo impiego per la preparazione esocellulare di anticorpi in forma di singola molecola da bacillus subtilis
US6737515B2 (en) * 1993-11-19 2004-05-18 Washington University Follicle stimulating hormone-glycosylation analogs
US6162905A (en) * 1996-11-07 2000-12-19 Ibsa Institut Biochimique S.A. FSH and LH separation and purification process
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US6414123B1 (en) 1997-10-21 2002-07-02 Vitro Diagnostics, Inc. Method for purifying FSH
US5990288A (en) * 1997-10-21 1999-11-23 Vitro Diagnostics, Inc. Method for purifying FSH
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
IL140984A0 (en) * 1998-07-23 2002-02-10 Lilly Co Eli Fsh and fsh variant formulations, products and methods
JP2002541213A (ja) 1999-04-13 2002-12-03 インヘール セラピューティック システムズ， インコーポレイテッド 不妊症の処置のための乾燥粉末処方物の肺投与
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
DE60112742T2 (de) * 2000-05-19 2006-02-02 Applied Research Systems Ars Holding N.V. Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
EP1351704B1 (en) * 2000-12-21 2007-03-07 Nektar Therapeutics Storage stable powder compositions of interleukin-4 receptor
UA87433C2 (ru) * 2001-10-22 2009-07-27 Еплайд Рісьорч Системз Ерс Холдінг Н.В. Гонадотропины для стимулирования фолликулогенеза
AU2002368265B2 (en) 2001-10-22 2007-06-07 Merck Serono Sa Mutant glycoproteins
ES2399047T3 (es) 2002-09-20 2013-03-25 Merck Serono Sa Derivados de piperazina y procedimiento de uso
EA200501548A1 (ru) * 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
AU2004226666B9 (en) * 2003-04-02 2010-04-08 Ares Trading S.A. Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant
AU2004248931B2 (en) * 2003-06-20 2009-07-16 Ares Trading S.A. Freeze-dried FSH / LH formulations
AU2004309040B2 (en) * 2003-12-22 2010-12-16 Ares Trading S.A. Method for purifying FSH
US20070270339A1 (en) * 2004-04-23 2007-11-22 Serono, Inc. Use of GPCR54 Ligands for the Treatment of Infertility
DE602005009856D1 (de) * 2004-11-09 2008-10-30 Ares Trading Sa Verfahren zur reinigung von fsh
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
DK1917276T3 (en) 2005-08-26 2018-05-07 Ares Trading Sa Process for Preparation of Glycosylated Interferon Beta
US20100069387A1 (en) 2005-09-07 2010-03-18 Palmer Stephen S IKK Inhibitors for the Treatment of Endometriosis
KR20080043301A (ko) * 2005-09-14 2008-05-16 아레스 트레이딩 에스.에이. 폴록사머의 정량 방법
AU2006323925B2 (en) 2005-12-09 2012-08-02 Ares Trading S.A. Method for purifying FSH or a FSH mutant
CA2685308A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
UA103598C2 (uk) 2007-06-28 2013-11-11 Биодженерикс Аг Клон клітин, що продукують fsh
EP2412385A1 (en) 2008-02-08 2012-02-01 BioGeneriX AG Liquid formulation of FSH
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
JP2009273427A (ja) 2008-05-16 2009-11-26 Jcr Pharmaceuticals Co Ltd 組換え体ヒトｆｓｈの製造方法
KR101761168B1 (ko) 2009-04-01 2017-07-25 바이오제너릭스 게엠베하 재조합 ｆｓｈ 정제 방법
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
RU2438680C1 (ru) * 2010-10-07 2012-01-10 Федеральное государственное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ получения препарата фолликулостимулирующего гормона из аденогипофизов животных
WO2012131306A1 (en) 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
CN103509121B (zh) 2012-11-22 2015-01-28 苏州康宁杰瑞生物科技有限公司 一种fsh融合蛋白及其制备方法和用途
EP3192556B1 (en) 2014-09-11 2024-08-14 Hisamitsu Pharmaceutical Co., Inc. Microneedle device
CN107106658B (zh) 2014-10-27 2021-07-09 久光制药株式会社 含有基因重组型卵泡刺激激素的微针装置
EP3525810A2 (en) * 2016-10-11 2019-08-21 Oncogreen Therapeutics SA Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors
CN111349154A (zh) * 2018-12-21 2020-06-30 江苏众红生物工程创药研究院有限公司 一种重组人促卵泡激素及其制备方法和药物应用
KR102752764B1 (ko) * 2019-12-26 2025-01-14 주식회사 엘지화학 여포 자극 호르몬의 정제 방법
CN116120449A (zh) * 2021-07-09 2023-05-16 苏州晟济药业有限公司 抗体以及包含其的结合剂、免疫吸附材料及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852422A (en) * 1971-06-26 1974-12-03 Serono Ist Farm Long-active gonadotropins
SU618113A1 (ru) * 1976-11-19 1978-08-05 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Способ получени фолликулостимулирующего гормона
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
EP0161063B1 (en) * 1984-04-03 1991-07-24 Serono Laboratories, Inc. Method of inducing ovulation
GB8510177D0 (en) * 1985-04-22 1985-05-30 Public Health Laborotory Servi Isolating pituitary glycoprotein hormones
GB2174600B (en) * 1985-05-10 1989-12-20 Univ Melbourne Induction of ovulation in mares
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario

Also Published As

Publication number Publication date
NO890805D0 (no) 1989-02-24
ATE115148T1 (de) 1994-12-15
US5767067A (en) 1998-06-16
JPH02500840A (ja) 1990-03-22
DK89989D0 (da) 1989-02-24
LV10628A (lv) 1995-04-20
NO177498C (no) 1995-09-27
UA19101A (uk) 1997-12-25
DE3852383D1 (de) 1995-01-19
US5128453A (en) 1992-07-07
LT3999B (en) 1996-06-25
CN1117873A (zh) 1996-03-06
AR243241A1 (es) 1993-07-30
GEP19971042B (en) 1997-06-13
GR880100418A (el) 1989-03-08
DK173349B1 (da) 2000-08-07
FI96608C (fi) 1996-07-25
EP0322438B1 (en) 1994-12-07
CN1030589A (zh) 1989-01-25
LTIP1654A (en) 1995-08-25
FI96608B (fi) 1996-04-15
ES2009948A6 (es) 1989-10-16
ZA884492B (en) 1989-05-30
IL86847A0 (en) 1988-11-30
MX9203471A (es) 1992-09-01
HK143195A (en) 1995-09-15
AU1962088A (en) 1989-01-19
US5840857A (en) 1998-11-24
AU615930B2 (en) 1988-06-24
IT1206302B (it) 1989-04-14
JP2523843B2 (ja) 1996-08-14
LV10628B (en) 1995-10-20
KR890701626A (ko) 1989-12-21
RU2105012C1 (ru) 1998-02-20
IT8748110A0 (it) 1987-06-26
FI890893A0 (fi) 1989-02-24
GR1003186B (el) 1999-09-01
FI890893L (fi) 1989-02-24
IL86847A (en) 1997-11-20
DE3852383T2 (de) 1995-04-20
CN1031714C (zh) 1996-05-01
LV10196B (en) 1995-04-20
CA1340649C (en) 1999-07-13
DK89989A (da) 1989-02-24
CN1069062C (zh) 2001-08-01
NO890805L (no) 1989-02-24
EP0322438A1 (en) 1989-07-05
GEP19981274B (en) 1998-05-06
NO177498B (no) 1995-06-19
WO1988010270A1 (en) 1988-12-29
LTIP1652A (en) 1995-08-25
KR0156565B1 (ko) 1998-10-15
RU2059412C1 (ru) 1996-05-10
LT4018B (en) 1996-08-26

Similar Documents

Publication Publication Date Title
LTIP1654A (en) Protein, biologically active hormone, pharmaceutical preparation
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE3676235D1 (de) Arzneizubereitung mit verzoegerter wirkstoffabgabe.
FI870809A0 (fi) Menetelmä farmaseuttisessa valmisteessa käytettävän, veteen liukenevan, biologisesti aktiivisen, konjugoidun proteiinin valmistamiseksi
DK161386A (da) Farmaceutisk insulinpraeparat til intranasal indgivelse
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
DK453585A (da) Laegemiddel-indgivelsessystem
BR8702654A (pt) Sistema para administracao pulsatil de drogas
IT1221024B (it) Sistema di somministrazione di farmaci
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
EP0129582A4 (en) BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION.
DE3682960D1 (de) Pharmazeutische praeparate.
DE3576118D1 (de) Pharmazeutische praeparate.
FI864164A7 (fi) Ihmis- -interferonin biologisesti aktiivisia johdoksia, niiden valmistus ja tällaisia johdoksia sisältävlääkkeitä.
DK527487A (da) Farmaceutiske praeparater med forlaenget afgivelse
DK415388A (da) Farmaceutiske praeparater indeholdende pyrimidinderivater og fremgangsmaade til fremstilling deraf
DK590987A (da) Peptid og farmaceutisk praeparat indeholdende et saadant peptid
DK183585D0 (da) Iminothiazolidinderivater, deres fremstilling og farmaceutiske praeparater deraf
DK370085D0 (da) Antianafylaktisk virksomme farmaceutiske praeparater
DK428187A (da) Farmaceutiske administrationssystemer indeholdende kemotaktiske peptider